Xing Chen

6PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 08, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Justin F Gainor, Manish R Patel, Jeffrey S Weber

|Aug 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.

Spyros Chalkias, Jordan L Whatley, Frank Eder

|Aug 23, 2023
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.

Spyros Chalkias, Charles Harper, Keith Vrbicky

|Oct 06, 2022
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.

Spyros Chalkias, Frank Eder, Brandon Essink

|Sep 16, 2022
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.

Spyros Chalkias, Charles Harper, Keith Vrbicky

Pageof 1

Frequent Collaborators

3 joint publications

Darin K Edwards

3 joint publications

Stephen Walsh

2 joint publications

Joanne E Tomassini

1 joint publications

Rolando Pajon